Ibex Investors’s Repligen RGEN Stock Holding History

Ibex Investors’s Portfolio RGEN Stock Details RGEN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-4,246	Closed	-$224K	–	120
2018 Q4	$224K	Buy	+4,246	New	+$249K	0.04%	91

Other funds holding RGEN

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

FAM

Fred Alger Management New York $30B AUM 76.99% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return

Ibex Investors's RGEN Position: Q1 2019 in Review

Ibex Investors sold out of Repligen (RGEN) in Q1 2019, closing a stake of 4,246 shares — an estimated $224K sold.

Ibex Investors first reported a position in RGEN in Q4 2018 and held it in 1 quarter. The position peaked at $224K in Q4 2018. 252 funds tracked by Wall St. Rank hold RGEN as of Q1 2019.

Ibex Investors reported no remaining Repligen position as of Q1 2019 after selling out during the quarter.
Ibex Investors sold 4,246 Repligen shares in Q1 2019, an estimated $224K.
Ibex Investors first reported a position in Repligen in Q4 2018 and held it in 1 quarter.
Ibex Investors's Repligen position peaked at $224K in Q4 2018.
252 funds tracked by Wall St. Rank held Repligen as of Q1 2019.

Based on Ibex Investors's 13F filing for Q1 2019, filed 7 May 2019.